Thai FDA asks Pfizer Thailand to seek full approval of its mRNA vaccine

14 Sept 07:48 Key points summarised by AI

The Thai FDA is urging Pfizer Thailand to submit additional data to secure full approval for its mRNA vaccine, moving beyond its current Emergency Use Authorization (EUA).
Full approval, potentially granted within 30 days of data submission, would enable the vaccine to be commercially marketed in Thailand, similar to flu vaccines.
This request follows the US FDA's recent full approval of the Pfizer-BioNTech vaccine, setting a precedent for robust regulatory standards for COVID-19 vaccines.

Uthenthawai students and alumni declare truce with Pathumwan rivals

Yesterday 20:34 Key points summarised by AI

Uthenthawai students and alumni have pledged to cease violent clashes with Pathumwan Institute rivals, coinciding with their campus's reopening after a 90-day closure.
The Minister of Higher Education is mediating the long-running conflict, while the campus closure has significantly disrupted in-person classes and laboratory work for over 1,000 students.
Uthenthawai resists relocation from its current site, citing a historical land grant from King Rama VI, despite Chulalongkorn University's plans to reclaim the land for an educational hub.
Concerns are mounting over the legality of the campus closure, its detrimental impact on uninvolved students, and the potential commercial development of the land, which critics argue contradicts the late King Rama VI's intentions.